407
Views
29
CrossRef citations to date
0
Altmetric
Infection

Intralesional immunotherapy with tuberculin purified protein derivative (PPD) in recalcitrant wart: A randomized, placebo-controlled, double-blind clinical trial including an extra group of candidates for cryotherapy

, , &
Pages 173-178 | Received 25 Mar 2015, Accepted 06 Jul 2015, Published online: 07 Sep 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Pati Aji Achdiat, Yunitasari, Hermin Aminah Usman & Retno Hesty Maharani. (2023) A Case of Genital and Extragenital Warts Unresponsive to Immunotherapy Using Measles, Mumps, Rubella Vaccine. International Medical Case Reports Journal 16, pages 739-746.
Read now
Kanchana Leerunyakul, Sasima Thammarucha, Poonkiat Suchonwanit & Suthinee Rutnin. (2022) A comprehensive review of treatment options for recalcitrant nongenital cutaneous warts. Journal of Dermatological Treatment 33:1, pages 23-40.
Read now
Fathia M. Khattab & Mohamed M. Nasr. (2020) A comparative study of topical cantharidin and intralesional PPD to treat molluscum contagiosum. Journal of Dermatological Treatment 31:8, pages 850-854.
Read now
Viktor A. Zouboulis & Christos C. Zouboulis. (2017) Small cryotherapy devices for the treatment of skin warts. Journal of Dermatological Treatment 28:8, pages 745-750.
Read now

Articles from other publishers (25)

Sara M. Awad, Ahmed S. Gomaa, Hiba A. Hassan & Yasmin M. Tawfik. (2023) Efficacy of Cryotherapy Combined With Intralesional Purified Protein Derivative (PPD) Versus Intralesional PPD Monotherapy in the Treatment of Multiple Common Warts. Journal of Cutaneous Medicine and Surgery 27:2, pages 117-125.
Crossref
Suthinee Rutnin, Amornrut Namasondhi, Cherrin Pomsoong, Chaninan Kositkuljorn, Tanaporn Anuntrangsee & Kunlawat Thadanipon. (2023) Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial. Dermatology 239:1, pages 109-115.
Crossref
Ghada Farouk Mohammed, Mohammed Saleh Al‐Dhubaibi, Saleh Salem Bahaj & Ahmed Ibrahim Abd Elneam. (2022) Systemic immunotherapy for the treatment of warts: A literature review. Journal of Cosmetic Dermatology 21:11, pages 5532-5536.
Crossref
Amany Awad, Ahmed Fawzi Ismael, Manar Sallam & Soheir Abdelgaber. (2022) Intralesional purified protein derivative versus zinc sulfate 2% in the treatment of pediatric warts: Clinical and dermoscopic evaluation. Journal of Cosmetic Dermatology 21:10, pages 4637-4645.
Crossref
Noha Z. Tawfik, Moustafa M. K. Eyada, Reem E. Abdel El Hamid & Halim Maher Halim. (2022) Intralesional injection of purified protein derivative versus Candida antigen in treatment of genital warts. Dermatologic Therapy 35:10.
Crossref
Hyun Jeong Ju, Hye Ree Park, Ji Yoon Kim, Gyong Moon Kim, Jung Min Bae & Ji Hae Lee. (2022) Intralesional immunotherapy for non-genital warts: A systematic review and meta-analysis. Indian Journal of Dermatology, Venereology and Leprology 88, pages 724-737.
Crossref
Nagwa Diab, Hend Atef & Eman Salah. (2022) Comparative efficacy of using a combination of intralesional purified protein derivative with low dose isotretinoin in the treatment of recalcitrant common warts. Dermatologic Therapy 35:6.
Crossref
Ahmad A. Nofal, Basma M. Elkholy, Esraa R. Abd-Elmonsef & Hagar O. Nofal. (2022) Triple Intralesional Antigen Immunotherapy versus Monoantigen in the Treatment of Multiple Recalcitrant Warts. Dermatology and Therapy 12:5, pages 1225-1237.
Crossref
Hassan Ibrahim, Moustafa El Taieb, Essam Nada, Ebtehal Kamal & Eisa Hegazy. (2022) Combined intralesional injection of tuberculin purified protein derivative plus cryotherapy versus each alone in the treatment of multiple common warts. Dermatologic Therapy 35:4.
Crossref
Alpana Mohta, SureshKumar Jain, RajeshDutt Mehta & Aakanksha Arora. (2022) Intralesional purified protein derivative of tuberculin versus intralesional mycobacterium W vaccine in treatment of recalcitrant extragenital warts: A randomized, single-blinded, comparative study. Indian Journal of Dermatology 67:1, pages 26.
Crossref
Caroline Fenton & Connie Kang. (2021) Don’t despair over difficult-to-treat warts. Drugs & Therapy Perspectives 37:11, pages 503-507.
Crossref
Wan Syazween Lyana Wan Ahmad Kammal, Adawiyah Jamil & Norazirah Md Nor. (2021) Efficacy and safety of intralesional tuberculin purified protein derivative versus cryotherapy in the treatment of warts: An assessor‐blinded, randomized controlled trial. Dermatologic Therapy 34:5.
Crossref
Engi Seif E. Shaker, Noha N. Doghim, Arwa Mhammad Hassan, Samia S. Musafa & Mohamed M. Fawzy. (2021) Immunotherapy in cutaneous warts: comparative clinical Study between MMR vaccine, tuberculin, and BCG Vaccine. Journal of Cosmetic Dermatology 20:8, pages 2657-2666.
Crossref
Peter C. Friedman. (2021) Management of Difficult-to-Treat Warts: Traditional and New Approaches. American Journal of Clinical Dermatology 22:3, pages 379-394.
Crossref
Pragati Gogia, Gurvinder Pal Thami, Kavita Poonia, Mala Bhalla & Geeta Garg. (2021) Efficacy of tuberculin immunotherapy in verruca vulgaris: Our experience from single center from North‐West India and review of literature . Dermatologic Therapy.
Crossref
Yaser F. Mohammed, Hany S. Ibrahim, Marwa A. Elbarbary & Mohamed L. Elsaie. (2020) Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts. Journal of Cosmetic Dermatology.
Crossref
Sowmya Kaimal, Hima Gopinath & Venkatesh Premalatha. (2020) Intralesional immunotherapy with purified protein derivative (PPD) for cryotherapy‐resistant warts. International Journal of Dermatology 59:6, pages 726-729.
Crossref
Ahmad Nofal, Mohamed Soliman, Faten Hamdy & Rania Alakad. (2020) Intralesional Candida antigen versus intralesional tuberculin in the treatment of recalcitrant genital warts: A comparative study. Journal of the American Academy of Dermatology 82:6, pages 1512-1514.
Crossref
Jaime R. Fields, Sami K. Saikaly & Jennifer J. Schoch. (2020) Intralesional immunotherapy for pediatric warts: A review. Pediatric Dermatology 37:2, pages 265-271.
Crossref
Riza R. Milante, Abelaine Venida‐Tablizo & Daisy King‐Ismael. (2019) Efficacy and safety of single versus multiple intralesional immunotherapy with purified protein derivative (PPD) in the treatment of multiple verruca vulgaris. International Journal of Dermatology 58:12, pages 1477-1482.
Crossref
Samar Salman. (2019) Response to “Purified protein derivative as intralesional immunotherapy for treatment of warts: Selection of the appropriate population is crucial”. Journal of the American Academy of Dermatology 81:4, pages e103.
Crossref
Samar Salman, Mohamed Shehata Ahmed, Ahmed Mohamed Ibrahim, Omar Mohamed Mattar, Hassan El-Shirbiny, Sameh Sarsik, Ahmed M. Afifi, Ruba Marwan Anis, Nadim Aiman Yakoub Agha & Abdelrahman Ibrahim Abushouk. (2019) Intralesional immunotherapy for the treatment of warts: A network meta-analysis. Journal of the American Academy of Dermatology 80:4, pages 922-930.e4.
Crossref
Ryan S. Sefcik & Craig G. Burkhart. (2017) Wart Immunotherapies: A Short Review. The Open Dermatology Journal 11:1, pages 30-34.
Crossref
Sonia Raghukumar, B. C. Ravikumar, K. N. Vinay, M. R. Suresh, Archit Aggarwal & D. P. Yashovardhana. (2017) Intralesional Vitamin D 3 Injection in the Treatment of Recalcitrant Warts: A Novel Proposition . Journal of Cutaneous Medicine and Surgery 21:4, pages 320-324.
Crossref
Alaa E.A. Moubasher, Osama M. Hassan, Eman M.K. Youssef & Marwa M.A. Sabek. (2016) Intralesional injection of purified protein derivatives versus zinc sulfate 2% in recalcitrant palmar and/or plantar warts. Journal of the Egyptian Women?s Dermatologic Society 13:3, pages 151-158.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.